Comparing a fecal immunochemical test and circulating tumor DNA blood test for colorectal cancer screening adherence.
Geraldine Laven-LawErin Leigh SymondsJean M WinterGang ChenIngrid Helen K FlightDonna Hughes-BartonCarlene J WilsonGraeme Paul YoungPublished in: Journal of gastroenterology and hepatology (2024)
Targeted interventions to improve CRC screening awareness and increase patient health activation may improve CRC screening adherence. A ctDNA blood test may be a suitable CRC screening option to maintain CRC screening adherence in people who do not participate in screening with FIT.